Home    About NDEI   Site Map   FAQ   Contact Us   Feedback   
       Advanced Search    
Home
Slide Library
Literature Alerts
On Demand Activities
Case Studies
Newsletters
Live Events
Treatment Guidelines
Patient Education
Clinical Trials
Product Indications
Calendar Of Events
Glossary
Other Resources
CME Opportunities


Your Online Resource for Diabetes Treatment
Home > Literature Alerts > Archived by Topic > Other

Other


Add to Google
Aspirin use and risk of type 2 diabetes in apparently healthy men
Hayashino Y, Hennekens CH, Kurth T
Am J Med. 2009;122(4):374-379
Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial
Ogawa H, Nakayama M, Morimoto T, Uemura S, et al, for the Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial Investigators
JAMA. 2008;300(18):2134-2141
An assessment of the effect of thiazolidinedione exposure on the risk of myocardial infarction in type 2 diabetic patients
Koro CE, Fu Q, Stender M
Pharmacoepidemiol Drug Saf. 2008;17(10):989-986
Effect of a multifactorial intervention on mortality in type 2 diabetes.
Gaede P, Lund-Andersen H, Parving HH, Pedersen O
ACC Abstracts of the 48th Scientific Session. 358(6):580-91
Effects of torcetrapib in patients at high risk for coronary events
Barter PJ, Caulfield M, Eriksson M, Grundy SM, Kastelein JJ, Komajda M, Lopez-Sendon J, Mosca L, Tardif JC, Waters DD, Shear CL, Revkin JH, Buhr KA, Fisher MR, Tall AR, Brewer B; ILLUMINATE Investigators
N Engl J Med. 357(21):2109-22
Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial
Farmer A, Wade A, Goyder E, Yudkin P, French D, Craven A, Holman R, Kinmonth AL, Neil A.
ACC Abstracts of the 48th Scientific Session. 335(7611):132
Sildenafil citrate diminishes microalbuminuria and the percentage of A1c in male patients with type 2 diabetes.
Grover-Páez F, Villegas Rivera G, Guillén Ortíz R
ACC Abstracts of the 48th Scientific Session. 78(1):136-40
Relationship between insulin resistance and inflammatory markers and anti-inflammatory effect of losartan in patients with type 2 diabetes and hypertension
Park H, Hasegawa G, Obayashi H, et al
Clin Chimica Acta.. 2006;374:129-134
Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome
Bakris G, Molitch M, Hewkin A, et al, for the STAR Investigators
Diabetes Care. 2006;29:2592-2597
Hormone replacement therapy is associated with increased C-reactive protein in women with Type 2 diabetes in the Diabetes Heart Study
Bowden DW, Lohman K, Hsu FC, et al
Diabet Med. 2006;23:763-767
 

Clinical Bridges, Secaucus, NJ
Clinical Bridges is a division of KnowledgePoint360 Group, LLC.
Copyright © 2009 Clinical Bridges. All rights reserved.
National Diabetes Education Initiative, Clinical Bridges, and
KnowledgePoint360 are trademarks of KnowledgePoint360 Group, LLC.
Disclaimer Statement - Privacy Statement